{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-050320","form_type":"8-K","ticker":"VIVS","cik":"0001497253","company_name":"VivoSim Labs, INC.","filed_at":"2021-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.749754+00:00","generated_at":"2026-06-28T22:33:52.507898+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Organovo CFO Jonathan Lieber resigns; Thomas P. Hess appointed as President and CFO","bullets":["Jonathan Lieber resigned effective Oct 6, 2021, to pursue a full-time opportunity; no disagreement with the Company.","Thomas P. Hess, age 57, appointed President, CFO and Principal Financial Officer, effective Oct 6, 2021, through Danforth Advisors at $400/hour.","At Oct 5, 2021 annual meeting, 45.91% of shares constituted quorum; Alison Tjosvold Milhous elected Class I director.","Stockholders ratified Mayer Hoffman McCann P.C. as auditor for FY2022 and approved advisory say-on-pay and amendment to 2012 Equity Incentive Plan.","Plan amended to increase share reserve to 2,327,699 shares and impose annual per-person limits of 400,000 shares and $2,000,000 cash."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-050320","json":"https://secwatch.observer/filing/0001564590-21-050320.json","markdown":"https://secwatch.observer/filing/0001564590-21-050320.md","text":"https://secwatch.observer/filing/0001564590-21-050320.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497253/000156459021050320/0001564590-21-050320-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497253/000156459021050320/onvo-8k_20211005.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T22:33:52.507898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0db2b6ff15","claim":"Thomas P. Hess was appointed as President, Chief Financial Officer and Principal Financial Officer at VivoSim Labs, INC..","evidence_excerpt":"On October 6, 2021, the Company’s Board of Directors appointed Thomas P. Hess, age 57, as the Company’s newly appointed President, Chief Financial Officer and Principal Financial Officer, effective October 6, 2021, in connection with the resignation of Mr. Lieber.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000156459021050320/0001564590-21-050320-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, Chief Financial Officer and Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"6f3bc0a985","claim":"Jonathan Lieber resigned as President, Chief Financial Officer and Principal Financial Officer at VivoSim Labs, INC..","evidence_excerpt":"On October 6, 2021, Jonathan Lieber, the President, Chief Financial Officer and Principal Financial Officer of Organovo Holdings, Inc. (the “Company”), notified the Company of his intent to resign, effective October 6, 2021, from his part-time role to pursue a full-time opportunity.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497253/000156459021050320/0001564590-21-050320-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President, Chief Financial Officer and Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}